In 2025, the revenue of biotech company BioNTech SE stood at 2.87 billion euros, compared to around 17.3 billion euros in 2022. On November 9th, 2020, German biotech company BioNTech, in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
BioNTech, & U.S. Securities and Exchange Commission. (March 11, 2026). Revenue of BioNTech SE from 2017 to 2025 (in million euros) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1186010/annual-revenue-biontech/
BioNTech, und U.S. Securities and Exchange Commission. "Revenue of BioNTech SE from 2017 to 2025 (in million euros)." Chart. March 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1186010/annual-revenue-biontech/
BioNTech, U.S. Securities and Exchange Commission. (2026). Revenue of BioNTech SE from 2017 to 2025 (in million euros). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1186010/annual-revenue-biontech/
BioNTech, and U.S. Securities and Exchange Commission. "Revenue of Biontech Se from 2017 to 2025 (in Million Euros)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Mar 2026, /statistics/1186010/annual-revenue-biontech/
BioNTech & U.S. Securities and Exchange Commission, Revenue of BioNTech SE from 2017 to 2025 (in million euros) ÌÇÐÄÆƽâ°æ, /statistics/1186010/annual-revenue-biontech/ (last visited July 20, 2026)
Revenue of BioNTech SE from 2017 to 2025 (in million euros) [Graph], BioNTech, & U.S. Securities and Exchange Commission, March 11, 2026. [Online]. Available: /statistics/1186010/annual-revenue-biontech/
